Eligibility Rheumatoid Arthritis NCT00688103

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients had to be at least 18 years of age
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
fulfilled the 1987 revised classification criteria for ra by in american college of rheumatology (acr)
Beskrivning

Rheumatoid Arthritis

Datatyp

boolean

Alias
UMLS CUI [1]
C0003873
met the guidelines for the proper use of etn in japan (having at least 6 tender joints and 6 swollen joints
Beskrivning

Etanercept | Tender joint count | Swollen joint count

Datatyp

boolean

Alias
UMLS CUI [1]
C0717758
UMLS CUI [2]
C0451530
UMLS CUI [3]
C0451521
either serum c-reactive protein more than 2 mg/dl or esr no less than 28 mm at 1 hour, with adequate safety profiles)
Beskrivning

serum C-reactive protein measurement | Erythrocyte sedimentation rate measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C2229674
UMLS CUI [2]
C1176468
be acr functional class i-iii
Beskrivning

Rheumatoid Arthritis Class Functional

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0456387
UMLS CUI [1,3]
C0205245
have been receiving mtx 6 mg/week for a minimum of 3 months at a stable dose for at least 4 weeks at the time of study enrollment
Beskrivning

Methotrexate U/week Dose Stable

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0560588
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C0205360
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who required concurrent use of prednisone (psl) >10 mg/day, or its equivalent, were excluded from study entry
Beskrivning

Prednisone U/day | prednisolone U/day | prednisolone equivalent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0032952
UMLS CUI [1,2]
C0456683
UMLS CUI [2,1]
C0032950
UMLS CUI [2,2]
C0456683
UMLS CUI [3,1]
C0032950
UMLS CUI [3,2]
C3242703
the start of dose increment of psl equivalents within 3 months of the study enrollment
Beskrivning

Prednisolone equivalent Dose Increment

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0032950
UMLS CUI [1,2]
C3242703
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C1705117
experience of antirheumatic therapy except for mtx and psl equivalents
Beskrivning

Antirheumatic Agents | Methotrexate Excluded | Prednisolone equivalent Excluded

Datatyp

boolean

Alias
UMLS CUI [1]
C0003191
UMLS CUI [2,1]
C0025677
UMLS CUI [2,2]
C2828389
UMLS CUI [3,1]
C0032950
UMLS CUI [3,2]
C3242703
UMLS CUI [3,3]
C2828389
previous treatment with etn or any other biological treatment
Beskrivning

Etanercept | Biological treatment

Datatyp

boolean

Alias
UMLS CUI [1]
C0717758
UMLS CUI [2]
C1531518

Similar models

Eligibility Rheumatoid Arthritis NCT00688103

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patients had to be at least 18 years of age
boolean
C0001779 (UMLS CUI [1])
Rheumatoid Arthritis
Item
fulfilled the 1987 revised classification criteria for ra by in american college of rheumatology (acr)
boolean
C0003873 (UMLS CUI [1])
Etanercept | Tender joint count | Swollen joint count
Item
met the guidelines for the proper use of etn in japan (having at least 6 tender joints and 6 swollen joints
boolean
C0717758 (UMLS CUI [1])
C0451530 (UMLS CUI [2])
C0451521 (UMLS CUI [3])
serum C-reactive protein measurement | Erythrocyte sedimentation rate measurement
Item
either serum c-reactive protein more than 2 mg/dl or esr no less than 28 mm at 1 hour, with adequate safety profiles)
boolean
C2229674 (UMLS CUI [1])
C1176468 (UMLS CUI [2])
Rheumatoid Arthritis Class Functional
Item
be acr functional class i-iii
boolean
C0003873 (UMLS CUI [1,1])
C0456387 (UMLS CUI [1,2])
C0205245 (UMLS CUI [1,3])
Methotrexate U/week Dose Stable
Item
have been receiving mtx 6 mg/week for a minimum of 3 months at a stable dose for at least 4 weeks at the time of study enrollment
boolean
C0025677 (UMLS CUI [1,1])
C0560588 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0205360 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
Prednisone U/day | prednisolone U/day | prednisolone equivalent
Item
patients who required concurrent use of prednisone (psl) >10 mg/day, or its equivalent, were excluded from study entry
boolean
C0032952 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0032950 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C0032950 (UMLS CUI [3,1])
C3242703 (UMLS CUI [3,2])
Prednisolone equivalent Dose Increment
Item
the start of dose increment of psl equivalents within 3 months of the study enrollment
boolean
C0032950 (UMLS CUI [1,1])
C3242703 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C1705117 (UMLS CUI [1,4])
Antirheumatic Agents | Methotrexate Excluded | Prednisolone equivalent Excluded
Item
experience of antirheumatic therapy except for mtx and psl equivalents
boolean
C0003191 (UMLS CUI [1])
C0025677 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0032950 (UMLS CUI [3,1])
C3242703 (UMLS CUI [3,2])
C2828389 (UMLS CUI [3,3])
Etanercept | Biological treatment
Item
previous treatment with etn or any other biological treatment
boolean
C0717758 (UMLS CUI [1])
C1531518 (UMLS CUI [2])